In Brief: Diametrics Medical
This article was originally published in The Gray Sheet
Diametrics Medical: Completes acquisition of Biomedical Sensors Ltd. unit of Pfizer for $1.5 mil. cash and a six-year promissory note valued at $7.3 mil., the firm announces Nov. 7. Diametrics previously announced it was negotiating for the purchase ("The Gray Sheet" Oct. 28, In Brief). BSL, which becomes a subsidiary of Diametrics, will continue to be headed by Roy Johnson, president. Diametrics expects the addition of BSL's line of indwelling blood and tissue monitoring systems to double its sales and "significantly" enhance earnings potential...
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.